Deepak Cyril D’Souza

The Psychotomimetic Effects of Intravenous Delta-9-Tetrahydrocannabinol in Healthy Individuals: Implications for Psychosis

Deepak Cyril D’Souza, Edward Perry, Lisa Macdougall et al. · Neuropsychopharmacology · 2004 · 1K citations · Full text

Medicine, Pharmacology, Psychiatry +12

Delta-9-tetrahydrocannabinol effects in schizophrenia: Implications for cognition, psychosis, and addiction

Deepak Cyril D’Souza, Walid Abi‐Saab, Steven Madonick et al. · Biological Psychiatry · 2005 · 612 citations

Medicine, Neuroscience, Pharmacology +12

Deficits in Prefrontal Cortical and Extrastriatal Dopamine Release in Schizophrenia

Mark Slifstein, Elsmarieke van de Giessen, Jared X. Van Snellenberg et al. · JAMA Psychiatry · 2015 · 393 citations

Medicine, Neuroscience, Psychiatry +17

Preliminary evidence of attenuation of the disruptive effects of the NMDA glutamate receptor antagonist, ketamine, on working memory by pretreatment with the group II metabotropic glutamate receptor agonist, LY354740, in healthy human subjects

John H. Krystal, Walid Abi‐Saab, Edward Perry et al. · Psychopharmacology · 2004 · 274 citations

Medicine, Neuroscience, Pharmacology +15

Blunted Psychotomimetic and Amnestic Effects of Δ-9-Tetrahydrocannabinol in Frequent Users of Cannabis

Deepak Cyril D’Souza, Mohini Ranganathan, Gabriel Braley et al. · Neuropsychopharmacology · 2008 · 261 citations

Medicine, Neuroscience, Pharmacology +14